Payer
In Teladoc's first earnings call as a publicly traded company, CEO Jason Gorevic and CFO Mark Hirschhorn reported positive earnings figures, were upfront about the costs of ongoing lawsuits, and even talked a little about future plans.
Following a small initial study, a UK-based startup reports that its digital health platform can decrease pain and stiffness in patients with musculoskeletal disorders (MSDs).
UnitedHealthcare has added new access options to its Health4Me app for Medicaid and CHIP beneficiaries in 17 states.
Chicago-based Zest Health, which has developed an app that helps people view and understand their health benefits, raised $6 million from 7wire Ventures, Lightbank, Zaffre Investments, Martin Ventures, Dallas Venture Partners, and LSAN/Azimuth Ventures.
Cigna Envoy, the insurance company's app for American employees living abroad, has added a mobile claims function that allows users to file a claim by taking a picture of a receipt.
A Junto Health working group meets at the last team summit.
San Francisco-based Limelight Health, which has developed a white-labeled health insurance quoting app, announced that it raised $3 million from MassMutual Ventures, the corporate venture capital arm of Massachusetts Mutual Life Insurance Company (MassMutual), and AXA Strategic Ventures.
AmeriHealth Caritas, a Medicaid managed care organization, has partnered with Palo Alto-based Theranos, which is working on a smaller, cheaper, alternative to common lab blood tests, to offer Theranos' services to its Medicaid members.
Philadelphia-based Picwell, which helps consumers choose a health plan, has raised $4 million in a round led by MassMutual Ventures, which is the corporate venture capital arm of Massachusetts Mutual Life Insurance Company.
Welkin Health, a San Francisco-based population health management company that provides a combination of mobile, web, and telephone-based coaching programs, has raised $2 million in seed funding and announced its first major pilot, which is with Humana's Innovation Group.